| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
2017
|
42 |
6 |
p. 879-880
|
artikel
|
| 2 |
Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species
|
Zhang, Ruiya
|
|
2017
|
42 |
6 |
p. 981-992
|
artikel
|
| 3 |
Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor
|
Hussein, Ziad
|
|
2017
|
42 |
6 |
p. 903-914
|
artikel
|
| 4 |
Comments on: “Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension”
|
Srinivas, Nuggehally R.
|
|
2017
|
42 |
6 |
p. 1019-1021
|
artikel
|
| 5 |
Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis
|
Abd Rahman, Azrin N.
|
|
2017
|
42 |
6 |
p. 993-1004
|
artikel
|
| 6 |
Effect of Long-term In Vitro Lithium Exposure on mRNA Levels of Claudin-3, CYP1A1, ABCG2 and GSTM3 Genes in the hCMEC/D3 Human Brain Endothelial Cell Line
|
Shawahna, Ramzi
|
|
2017
|
42 |
6 |
p. 1013-1017
|
artikel
|
| 7 |
Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study
|
Wang, Yi-lin
|
|
2017
|
42 |
6 |
p. 935-942
|
artikel
|
| 8 |
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
|
Golocorbin-Kon, Svetlana
|
|
2017
|
42 |
6 |
p. 1005-1011
|
artikel
|
| 9 |
Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis
|
Marchand, Mathilde
|
|
2017
|
42 |
6 |
p. 943-954
|
artikel
|
| 10 |
Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics
|
Suzuki, Eiko
|
|
2017
|
42 |
6 |
p. 965-972
|
artikel
|
| 11 |
Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations
|
Rhee, Su-jin
|
|
2017
|
42 |
6 |
p. 973-980
|
artikel
|
| 12 |
Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar® in Children with Acute Lymphoblastic Leukemia
|
Würthwein, Gudrun
|
|
2017
|
42 |
6 |
p. 955-963
|
artikel
|
| 13 |
Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L
|
Waters, Nigel J.
|
|
2017
|
42 |
6 |
p. 891-901
|
artikel
|
| 14 |
Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies
|
Dash, Ranjeet Prasad
|
|
2017
|
42 |
6 |
p. 915-933
|
artikel
|
| 15 |
The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
|
Mikov, Momir
|
|
2017
|
42 |
6 |
p. 881-890
|
artikel
|
Tijdschrift beschrijving